instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Herpes simplex'? | Life-threatening oral mucositis following chemotherapy in a pediatric patient.
Severe oral mucositis as a complication of chemotherapy may lead to airway obstruction and require prolonged intubation. As its course is consistent with the course of neutropenia, airway management strategies should be determined individual... | Recovered | ReactionOutcome | CC BY-NC-ND | 34136255 | 19,821,048 | 2021-06 |
What was the outcome of reaction 'Mouth haemorrhage'? | Life-threatening oral mucositis following chemotherapy in a pediatric patient.
Severe oral mucositis as a complication of chemotherapy may lead to airway obstruction and require prolonged intubation. As its course is consistent with the course of neutropenia, airway management strategies should be determined individual... | Recovered | ReactionOutcome | CC BY-NC-ND | 34136255 | 19,821,048 | 2021-06 |
What was the outcome of reaction 'Nutritional condition abnormal'? | Life-threatening oral mucositis following chemotherapy in a pediatric patient.
Severe oral mucositis as a complication of chemotherapy may lead to airway obstruction and require prolonged intubation. As its course is consistent with the course of neutropenia, airway management strategies should be determined individual... | Recovered | ReactionOutcome | CC BY-NC-ND | 34136255 | 19,821,048 | 2021-06 |
What was the outcome of reaction 'Obstructive airways disorder'? | Life-threatening oral mucositis following chemotherapy in a pediatric patient.
Severe oral mucositis as a complication of chemotherapy may lead to airway obstruction and require prolonged intubation. As its course is consistent with the course of neutropenia, airway management strategies should be determined individual... | Recovered | ReactionOutcome | CC BY-NC-ND | 34136255 | 19,821,048 | 2021-06 |
What was the outcome of reaction 'Respiratory tract oedema'? | Life-threatening oral mucositis following chemotherapy in a pediatric patient.
Severe oral mucositis as a complication of chemotherapy may lead to airway obstruction and require prolonged intubation. As its course is consistent with the course of neutropenia, airway management strategies should be determined individual... | Recovered | ReactionOutcome | CC BY-NC-ND | 34136255 | 19,821,048 | 2021-06 |
What was the outcome of reaction 'Shock haemorrhagic'? | Life-threatening oral mucositis following chemotherapy in a pediatric patient.
Severe oral mucositis as a complication of chemotherapy may lead to airway obstruction and require prolonged intubation. As its course is consistent with the course of neutropenia, airway management strategies should be determined individual... | Recovered | ReactionOutcome | CC BY-NC-ND | 34136255 | 19,821,048 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) is an aggressive disease with poor outcomes. Despite the in... | INOTUZUMAB OZOGAMICIN, PONATINIB | DrugsGivenReaction | CC BY | 34136291 | 19,465,730 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukaemia recurrent'. | Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) is an aggressive disease with poor outcomes. Despite the in... | INOTUZUMAB OZOGAMICIN, PONATINIB | DrugsGivenReaction | CC BY | 34136291 | 19,465,730 | 2021 |
What was the administration route of drug 'INOTUZUMAB OZOGAMICIN'? | Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) is an aggressive disease with poor outcomes. Despite the in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34136291 | 19,465,730 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | CEFTAZIDIME, CLADRIBINE, CYTARABINE, FILGRASTIM, HYDROXYUREA, MITOXANTRONE HYDROCHLORIDE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34136343 | 20,160,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal oedema'. | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | CLADRIBINE, CYTARABINE, FILGRASTIM, LOPERAMIDE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34136343 | 20,086,452 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | CYTARABINE, HYDROXYUREA | DrugsGivenReaction | CC BY-NC-ND | 34136343 | 20,095,961 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal dilatation'. | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | CLADRIBINE, CYTARABINE, FILGRASTIM, LOPERAMIDE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34136343 | 20,086,452 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | CEFTAZIDIME, CYTARABINE, HYDROXYUREA, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34136343 | 20,087,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenic colitis'. | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | CEFTAZIDIME, CYTARABINE, HYDROXYUREA, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34136343 | 20,087,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour lysis syndrome'. | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | CYTARABINE, HYDROXYUREA | DrugsGivenReaction | CC BY-NC-ND | 34136343 | 20,095,961 | 2021 |
What was the administration route of drug 'FILGRASTIM'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34136343 | 20,197,316 | 2021 |
What was the dosage of drug 'HYDROXYUREA'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | HYDROXYUREA | DrugDosageText | CC BY-NC-ND | 34136343 | 20,156,841 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34136343 | 20,160,055 | 2021 |
What was the outcome of reaction 'Gastroenteritis staphylococcal'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34136343 | 20,160,509 | 2021 |
What was the outcome of reaction 'Infection'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34136343 | 20,160,509 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34136343 | 20,160,509 | 2021 |
What was the outcome of reaction 'Neutropenia'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34136343 | 20,087,641 | 2021 |
What was the outcome of reaction 'Septic shock'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34136343 | 20,160,509 | 2021 |
What was the outcome of reaction 'Staphylococcal infection'? | Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics.
MRSA enterocolitis is under-recognized in the setting of PCR testing. In this case report, we describe risk factors, the importance of stool culture, and the third ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34136343 | 20,160,509 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperpyrexia'. | Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?
The combination of BRAF and MEK inhibitors represents the standard of care treatment for patients with metastatic BRAF-mutated melanoma, notwithstanding the high frequency of emergent resistanc... | DABRAFENIB, TRAMETINIB | DrugsGivenReaction | CC BY | 34136385 | 20,364,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?
The combination of BRAF and MEK inhibitors represents the standard of care treatment for patients with metastatic BRAF-mutated melanoma, notwithstanding the high frequency of emergent resistanc... | DABRAFENIB, TRAMETINIB | DrugsGivenReaction | CC BY | 34136385 | 20,364,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastatic malignant melanoma'. | Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?
The combination of BRAF and MEK inhibitors represents the standard of care treatment for patients with metastatic BRAF-mutated melanoma, notwithstanding the high frequency of emergent resistanc... | DABRAFENIB, TRAMETINIB | DrugsGivenReaction | CC BY | 34136385 | 20,364,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?
The combination of BRAF and MEK inhibitors represents the standard of care treatment for patients with metastatic BRAF-mutated melanoma, notwithstanding the high frequency of emergent resistanc... | DABRAFENIB, TRAMETINIB | DrugsGivenReaction | CC BY | 34136385 | 20,364,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control.
Despite the fact that there is an increasingly effective armoury of medications to treat diabetes, many people continue to have substantially elevated blood glucose levels. The purpose of this study w... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34136579 | 20,354,631 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control.
Despite the fact that there is an increasingly effective armoury of medications to treat diabetes, many people continue to have substantially elevated blood glucose levels. The purpose of this study w... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34136579 | 20,351,620 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Feeling abnormal'. | Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control.
Despite the fact that there is an increasingly effective armoury of medications to treat diabetes, many people continue to have substantially elevated blood glucose levels. The purpose of this study w... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34136579 | 20,351,576 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired work ability'. | Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control.
Despite the fact that there is an increasingly effective armoury of medications to treat diabetes, many people continue to have substantially elevated blood glucose levels. The purpose of this study w... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34136579 | 20,351,620 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control.
Despite the fact that there is an increasingly effective armoury of medications to treat diabetes, many people continue to have substantially elevated blood glucose levels. The purpose of this study w... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34136579 | 20,354,633 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34137349 | 20,128,224 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'SARS-CoV-2 test positive'. | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34137349 | 20,128,224 | 2021-11 |
What was the administration route of drug 'RITUXIMAB'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34137349 | 20,085,010 | 2021-11 |
What was the dosage of drug 'PREDNISOLONE'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | UNK, THIRD COURSE ON 01 DEC 2020 | DrugDosageText | CC BY-NC-ND | 34137349 | 20,106,831 | 2021-11 |
What was the dosage of drug 'PREDNISONE'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | RECEIVED 3RD DOSE ON 01/DEC/2020 | DrugDosageText | CC BY-NC-ND | 34137349 | 19,892,500 | 2021-11 |
What was the dosage of drug 'TEMOZOLOMIDE'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | UNK, FOR A TOTAL OF 7 DAYS | DrugDosageText | CC BY-NC-ND | 34137349 | 19,951,557 | 2021-11 |
What was the outcome of reaction 'COVID-19'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | Fatal | ReactionOutcome | CC BY-NC-ND | 34137349 | 20,142,234 | 2021-11 |
What was the outcome of reaction 'Cytopenia'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | Fatal | ReactionOutcome | CC BY-NC-ND | 34137349 | 20,085,010 | 2021-11 |
What was the outcome of reaction 'Respiratory failure'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | Fatal | ReactionOutcome | CC BY-NC-ND | 34137349 | 20,142,234 | 2021-11 |
What was the outcome of reaction 'SARS-CoV-2 test positive'? | SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
Immunocompromised patients shed SARS-CoV-2 for extended periods, but to our knowledge person-to-person transmission from late shedding has not been reported.
We present a case in which a COVID-19 patient infected another over 28 days after t... | Recovering | ReactionOutcome | CC BY-NC-ND | 34137349 | 20,128,224 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade.
Parenchymal brain metastases from prostate cancer are unusual and are associated with poor prognosis. Given the rarity of this entity, little is known about its molecular and histologic characteristics. ... | DOCETAXEL | DrugsGivenReaction | CC BY-NC | 34140335 | 20,027,267 | 2021-08 |
What was the outcome of reaction 'Disease progression'? | Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade.
Parenchymal brain metastases from prostate cancer are unusual and are associated with poor prognosis. Given the rarity of this entity, little is known about its molecular and histologic characteristics. ... | Fatal | ReactionOutcome | CC BY-NC | 34140335 | 20,027,267 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | FLUCONAZOLE, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34140877 | 19,001,305 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | AMPHOTERICIN B, FLUCONAZOLE, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34140877 | 19,610,693 | 2021-06 |
What was the administration route of drug 'AMPHOTERICIN B'? | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34140877 | 19,610,693 | 2021-06 |
What was the dosage of drug 'AMPHOTERICIN B'? | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | 1 MG/KG | DrugDosageText | CC BY-NC-ND | 34140877 | 19,610,693 | 2021-06 |
What was the dosage of drug 'WARFARIN SODIUM'? | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | FOR 3 WEEK DURATION | DrugDosageText | CC BY-NC-ND | 34140877 | 19,009,287 | 2021-06 |
What was the outcome of reaction 'Coagulopathy'? | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | Fatal | ReactionOutcome | CC BY-NC-ND | 34140877 | 19,610,693 | 2021-06 |
What was the outcome of reaction 'Drug ineffective'? | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | Fatal | ReactionOutcome | CC BY-NC-ND | 34140877 | 19,001,305 | 2021-06 |
What was the outcome of reaction 'Drug interaction'? | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | Fatal | ReactionOutcome | CC BY-NC-ND | 34140877 | 19,610,693 | 2021-06 |
What was the outcome of reaction 'Septic shock'? | Cryptococcal spondylodiscitis in a non-HIV patient with CD4 lymphocytopenia.
Infections that affect the intervertebral discs and vertebrae are known as spondylodiscitis. Such infections are commonly caused by pyogenic organisms, particularly Staphylococcus aureus, and hematogenous spread is the most common route. Non-p... | Fatal | ReactionOutcome | CC BY-NC-ND | 34140877 | 19,610,693 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Effective treatment of apatinib for chemotherapy-refractory advanced gastric carcinoma with AFP-secretion and HER2-positivity: A case report.
α-fetoprotein (AFP)-secreting gastric cancer (AFP-GC) is a relatively rare, aggressive malignancy among all GC types. However, no GC case with simultaneous expression of AFP and ... | DOCETAXEL, GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34141430 | 19,573,257 | 2021-08 |
What was the dosage of drug 'DOCETAXEL'? | Effective treatment of apatinib for chemotherapy-refractory advanced gastric carcinoma with AFP-secretion and HER2-positivity: A case report.
α-fetoprotein (AFP)-secreting gastric cancer (AFP-GC) is a relatively rare, aggressive malignancy among all GC types. However, no GC case with simultaneous expression of AFP and ... | ON DAY 1 | DrugDosageText | CC BY-NC-ND | 34141430 | 19,573,257 | 2021-08 |
What was the outcome of reaction 'Myelosuppression'? | Effective treatment of apatinib for chemotherapy-refractory advanced gastric carcinoma with AFP-secretion and HER2-positivity: A case report.
α-fetoprotein (AFP)-secreting gastric cancer (AFP-GC) is a relatively rare, aggressive malignancy among all GC types. However, no GC case with simultaneous expression of AFP and ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34141430 | 19,573,257 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrioventricular dissociation'. | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | AZITHROMYCIN ANHYDROUS, CALCITRIOL, CALCIUM CARBONATE, CHLOROQUINE, METOPROLOL, MYCOPHENOLIC ACID, NIFEDIPINE, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 34141440 | 19,000,136 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | AZITHROMYCIN ANHYDROUS, CALCITRIOL, CALCIUM CARBONATE, CHLOROQUINE, METOPROLOL, MYCOPHENOLATE MOFETIL, NIFEDIPINE, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 34141440 | 19,002,064 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | AZITHROMYCIN ANHYDROUS, CALCITRIOL, CALCIUM CARBONATE, CHLOROQUINE PHOSPHATE, METOPROLOL, MYCOPHENOLIC ACID, NIFEDIPINE, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 34141440 | 18,988,068 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram ST segment depression'. | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | AZITHROMYCIN ANHYDROUS, CALCITRIOL, CALCIUM CARBONATE, CHLOROQUINE, METOPROLOL, MYCOPHENOLIC ACID, NIFEDIPINE, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 34141440 | 19,000,136 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | AZITHROMYCIN ANHYDROUS, CALCITRIOL, CALCIUM CARBONATE, CHLOROQUINE, METOPROLOL, MYCOPHENOLIC ACID, NIFEDIPINE, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 34141440 | 19,000,136 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | AZITHROMYCIN ANHYDROUS, CALCITRIOL, CALCIUM CARBONATE, CHLOROQUINE, METOPROLOL, MYCOPHENOLIC ACID, NIFEDIPINE, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 34141440 | 19,490,640 | 2021-01 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Oral | DrugAdministrationRoute | CC BY-NC | 34141440 | 18,959,597 | 2021-01 |
What was the administration route of drug 'CHLOROQUINE'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Oral | DrugAdministrationRoute | CC BY-NC | 34141440 | 18,959,597 | 2021-01 |
What was the administration route of drug 'TACROLIMUS'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Oral | DrugAdministrationRoute | CC BY-NC | 34141440 | 19,000,136 | 2021-01 |
What was the outcome of reaction 'Atrial fibrillation'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 18,988,068 | 2021-01 |
What was the outcome of reaction 'Atrioventricular dissociation'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 19,000,136 | 2021-01 |
What was the outcome of reaction 'Cardiac arrest'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 19,002,064 | 2021-01 |
What was the outcome of reaction 'Cardiotoxicity'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 18,988,068 | 2021-01 |
What was the outcome of reaction 'Drug interaction'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 18,988,068 | 2021-01 |
What was the outcome of reaction 'Electrocardiogram ST segment depression'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 19,000,136 | 2021-01 |
What was the outcome of reaction 'Myocarditis'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 19,000,136 | 2021-01 |
What was the outcome of reaction 'Off label use'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 18,959,597 | 2021-01 |
What was the outcome of reaction 'Product use in unapproved indication'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Not recovered | ReactionOutcome | CC BY-NC | 34141440 | 19,490,640 | 2021-01 |
What was the outcome of reaction 'Tachycardia'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 18,959,597 | 2021-01 |
What was the outcome of reaction 'Ventricular tachycardia'? | Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans. However, the evidence about ... | Fatal | ReactionOutcome | CC BY-NC | 34141440 | 18,988,068 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute lymphocytic leukaemia'. | Hyperleukocytosis during clozapine treatment: A rare presentation of B-cell Acute lymphoblastic leukemia.
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophrenia. Unfortunately, a wide range of blood dyscrasias have been reported as adverse effects of this drug. Agranulocyt... | CLOZAPINE | DrugsGivenReaction | CC BY | 34141565 | 19,666,686 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'B precursor type acute leukaemia'. | Hyperleukocytosis during clozapine treatment: A rare presentation of B-cell Acute lymphoblastic leukemia.
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophrenia. Unfortunately, a wide range of blood dyscrasias have been reported as adverse effects of this drug. Agranulocyt... | CLOZAPINE | DrugsGivenReaction | CC BY | 34141565 | 19,640,326 | 2021 |
What was the administration route of drug 'CLOZAPINE'? | Hyperleukocytosis during clozapine treatment: A rare presentation of B-cell Acute lymphoblastic leukemia.
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophrenia. Unfortunately, a wide range of blood dyscrasias have been reported as adverse effects of this drug. Agranulocyt... | Oral | DrugAdministrationRoute | CC BY | 34141565 | 19,502,119 | 2021 |
What was the outcome of reaction 'Acute lymphocytic leukaemia'? | Hyperleukocytosis during clozapine treatment: A rare presentation of B-cell Acute lymphoblastic leukemia.
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophrenia. Unfortunately, a wide range of blood dyscrasias have been reported as adverse effects of this drug. Agranulocyt... | Recovered | ReactionOutcome | CC BY | 34141565 | 19,502,119 | 2021 |
What was the outcome of reaction 'B precursor type acute leukaemia'? | Hyperleukocytosis during clozapine treatment: A rare presentation of B-cell Acute lymphoblastic leukemia.
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophrenia. Unfortunately, a wide range of blood dyscrasias have been reported as adverse effects of this drug. Agranulocyt... | Recovering | ReactionOutcome | CC BY | 34141565 | 19,640,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrolyte imbalance'. | Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report.
BACKGROUND
Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or witho... | METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY-NC | 34141752 | 19,647,142 | 2021-06-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report.
BACKGROUND
Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or witho... | METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY-NC | 34141752 | 19,647,142 | 2021-06-06 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report.
BACKGROUND
Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or witho... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34141752 | 19,647,142 | 2021-06-06 |
What was the outcome of reaction 'Electrolyte imbalance'? | Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report.
BACKGROUND
Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or witho... | Recovered | ReactionOutcome | CC BY-NC | 34141752 | 19,647,142 | 2021-06-06 |
What was the outcome of reaction 'Hypokalaemia'? | Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report.
BACKGROUND
Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or witho... | Recovered | ReactionOutcome | CC BY-NC | 34141752 | 19,647,142 | 2021-06-06 |
What was the administration route of drug 'EMPAGLIFLOZIN'? | Chest pain in a heart transplant recipient: A case report.
BACKGROUND
Heart transplantation is recommended for the treatment of patients with refractory heart failure. Chest pain after heart transplantation is usually considered noncardiac owing to the denervated heart. However, data from case reports on tacrolimus-ind... | Oral | DrugAdministrationRoute | CC BY-NC | 34141754 | 19,392,836 | 2021-06-06 |
What was the administration route of drug 'TACROLIMUS'? | Chest pain in a heart transplant recipient: A case report.
BACKGROUND
Heart transplantation is recommended for the treatment of patients with refractory heart failure. Chest pain after heart transplantation is usually considered noncardiac owing to the denervated heart. However, data from case reports on tacrolimus-ind... | Oral | DrugAdministrationRoute | CC BY-NC | 34141754 | 19,392,836 | 2021-06-06 |
What was the dosage of drug 'EMPAGLIFLOZIN'? | Chest pain in a heart transplant recipient: A case report.
BACKGROUND
Heart transplantation is recommended for the treatment of patients with refractory heart failure. Chest pain after heart transplantation is usually considered noncardiac owing to the denervated heart. However, data from case reports on tacrolimus-ind... | 12.5/850 MG, TWICE DAILY | DrugDosageText | CC BY-NC | 34141754 | 19,392,836 | 2021-06-06 |
What was the dosage of drug 'EVEROLIMUS'? | Chest pain in a heart transplant recipient: A case report.
BACKGROUND
Heart transplantation is recommended for the treatment of patients with refractory heart failure. Chest pain after heart transplantation is usually considered noncardiac owing to the denervated heart. However, data from case reports on tacrolimus-ind... | 0.5 UNK, TWICE DAILY | DrugDosageText | CC BY-NC | 34141754 | 19,392,836 | 2021-06-06 |
What was the dosage of drug 'TACROLIMUS'? | Chest pain in a heart transplant recipient: A case report.
BACKGROUND
Heart transplantation is recommended for the treatment of patients with refractory heart failure. Chest pain after heart transplantation is usually considered noncardiac owing to the denervated heart. However, data from case reports on tacrolimus-ind... | 1 mg (milligrams). | DrugDosage | CC BY-NC | 34141754 | 19,392,836 | 2021-06-06 |
What was the outcome of reaction 'Oesophageal achalasia'? | Chest pain in a heart transplant recipient: A case report.
BACKGROUND
Heart transplantation is recommended for the treatment of patients with refractory heart failure. Chest pain after heart transplantation is usually considered noncardiac owing to the denervated heart. However, data from case reports on tacrolimus-ind... | Recovered | ReactionOutcome | CC BY-NC | 34141754 | 19,392,836 | 2021-06-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Acute inferior myocardial infarction in a young man with testicular seminoma: A case report.
BACKGROUND
Atherosclerosis represents the main cause of myocardial infarction (MI); other causes such as coronary embolism, vasospasm, coronary-dissection or drug use are much rarely encountered, but should be considered in les... | BLEOMYCIN SULFATE, CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC | 34141764 | 19,628,647 | 2021-06-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombosis'. | Acute inferior myocardial infarction in a young man with testicular seminoma: A case report.
BACKGROUND
Atherosclerosis represents the main cause of myocardial infarction (MI); other causes such as coronary embolism, vasospasm, coronary-dissection or drug use are much rarely encountered, but should be considered in les... | BLEOMYCIN SULFATE, CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC | 34141764 | 19,471,662 | 2021-06-06 |
What was the outcome of reaction 'Acute myocardial infarction'? | Acute inferior myocardial infarction in a young man with testicular seminoma: A case report.
BACKGROUND
Atherosclerosis represents the main cause of myocardial infarction (MI); other causes such as coronary embolism, vasospasm, coronary-dissection or drug use are much rarely encountered, but should be considered in les... | Recovered | ReactionOutcome | CC BY-NC | 34141764 | 19,431,176 | 2021-06-06 |
What was the outcome of reaction 'Thrombosis'? | Acute inferior myocardial infarction in a young man with testicular seminoma: A case report.
BACKGROUND
Atherosclerosis represents the main cause of myocardial infarction (MI); other causes such as coronary embolism, vasospasm, coronary-dissection or drug use are much rarely encountered, but should be considered in les... | Recovered | ReactionOutcome | CC BY-NC | 34141764 | 19,471,662 | 2021-06-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palmar-plantar erythrodysaesthesia syndrome'. | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | ADO-TRASTUZUMAB EMTANSINE, ANASTROZOLE, CAPECITABINE, EXEMESTANE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Scar'. | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | ADO-TRASTUZUMAB EMTANSINE, ANASTROZOLE, CAPECITABINE, EXEMESTANE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.